Related Experiment Video
Updated: Jul 13, 2026
08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Proteomics in cancer
1Department of Surgery, University of Magdeburg, Germany.
Advances in Clinical Chemistry
|August 9, 2007
Summary
Proteomic studies offer potential for cancer diagnostics and therapeutics, but face challenges in data reproducibility and standardization. Overcoming these hurdles through improved study design and data integration is key to advancing cancer proteomics.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Proteomic studies generate valuable data for cancer diagnostics, prognostics, and therapeutics.
- Key technologies include two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and mass spectrometry (MS).
- Emerging technologies like SELDI-TOF-MS, isotope-coded affinity tag technology, and various arrays offer alternative approaches.
Purpose of the Study:
- To highlight the potential of proteomic studies in human cancer research.
- To address the challenges hindering the confirmation and application of proteomic technologies.
- To emphasize the need for standardized data handling and study design in cancer proteomics.
Main Methods:
- Utilizes two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and mass spectrometry (MS) for tissue analysis.
- Employs surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-MS for serum/plasma analysis.
- Considers alternative proteomic technologies such as isotope-coded affinity tag technology, reverse-phase protein arrays, and antibody microarrays.
Main Results:
- Lack of overlap between studies and issues like non-uniform criteria, small patient numbers, and poor reproducibility impede technology confirmation.
- Despite challenges, proteomic approaches show significant potential for identifying novel cancer diagnostic biomarkers.
- Therapeutic proteomics faces complexity but promises major contributions through large-scale dataset synthesis and comparison.
Conclusions:
- Standardized processes for data storage and retrieval across different technologies and research groups are essential.
- Shifting focus from technology development to study design, data organization, and mining is crucial for clinical applications.
- Addressing reproducibility and standardization issues will unlock the full potential of cancer proteomics for clinical questions.
More Related Videos
Related Concept Videos
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...